Kindeva Opens New UK HQ and Manufacturing Site for the Development of Next-Generation Propellants

Kindeva, a global CDMO and drug delivery expert, has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park, Loughborough. The facility represents a significant expansion in Kindeva’s MDI services and will develop and test next-generation propellants (NGP) as the industry prepares to move to more...

Inaphaea BioLabs Accelerates Precision Oncology with Strategic Partnerships, New Cancer Models, and Expanded Capabilities

Inaphaea BioLabs, the wholly owned translational Contract Research Organisation of ValiRx Plc, has announced a series of major initiatives over the past three months that significantly advance its role in translational cancer research, drug discovery, and personalised medicine. Under the leadership of Mark Eccleston, the recently appointed CEO of parent...

Acquisition enhances Gateley’s trade mark practice

Professional services group Gateley has significantly enhanced its growing trade mark practice following the acquisition of boutique IP firm Groom Wilkes & Wright LLP (GWW). GWW, which specialises in every aspect of trade mark and design law, was acquired in a move that significantly enhances the already considerable IP expertise...

Single manufacturer & supplier required for human skin patch: Formulation, manufacture, and packing

Opportunity Company:  Nottingham-based MedTech company Requires: Seeking a single manufacturer and supplier for the formulation, manufacture, and packing of a skin patch to be applied to the human body for up to 24 hours Service provider requirements • Minimum 10 years’ experience in skin patch formulation • Established raw ingredient...